Securities code: 002252 securities abbreviation: Shanghai Raas Blood Products Co.Ltd(002252) Announcement No.: 2022-001 Shanghai Raas Blood Products Co.Ltd(002252)
About the passive reduction plan of Laishi China Co., Ltd
Announcement of more than half of the reduction
RAAS China Limited, a shareholder holding more than 5%, guarantees that the information provided to the company is true, accurate and complete without false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the contents of the announcement are consistent with the information provided by the shareholder RAAS China Limited.
Shanghai Raas Blood Products Co.Ltd(002252) (the “company”) disclosed the pre disclosure announcement on the passive reduction of shares of Laishi China (Announcement No.: 2021-062) on November 26, 2021. The shareholder raaschina Limited (Laishi China Co., Ltd., “Laishi China”) received the sale notice from Changsha intermediate people’s Court of Hunan Province (“Changsha intermediate people’s court”), Changsha intermediate people’s court plans to entrust Caixin securities Xiangjiang Middle Road business department to sell 35480000 Shanghai Raas Blood Products Co.Ltd(002252) shares pledged by LES China to Bank Of Changsha Co.Ltd(601577) Nancheng sub branch through centralized bidding in the secondary market, which may lead to passive reduction of holdings by LES China.
According to the provisions on the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies, the detailed rules for the implementation of the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies of Shenzhen Stock Exchange and other relevant provisions, shareholders shall disclose the progress of the reduction when more than half of the above passive reduction plans are reduced. As of January 4, 2022, the passive reduction plan has reduced the number of shares by more than half. The company received the notification letter on the passive reduction plan of the company by more than half on January 5, 2022. During the passive reduction, the passive reduction plan reduced the total number of shares of the company by means of centralized bidding transaction (accounting for 0.27% of the total share capital of the company), The passive reduction plan did not reduce the company’s shares through the block trading system of Shenzhen Stock Exchange. The implementation of the pre disclosed passive reduction plan is hereby announced as follows:
1、 Share reduction in this passive reduction plan
Name of shareholder reduction method average price of reduction during reduction quantity of reduction proportion of reduced shares in total shares (yuan / share) (share) of the company
Centralized bidding transaction 6.60744563530.07% on December 27, 2021
Centralized bidding transaction 6.59636694890.05% on December 28, 2021
Rex China centralized bidding transaction on December 29, 2021 6.65730680160.05%
Centralized bidding transaction 6.67125980210.04% on December 30, 2021
Centralized bidding transaction 6.80822238640.03% on December 31, 2021
Centralized bidding transaction 6.89619212210.03% on January 4, 2022
Total — 179369640.27%
Remarks: 1. The above reduction is the passive reduction of Laishi China; 2. Source of shares: shares before initial public offering and non-public offering (including the part of capital reserve converted into share capital).
2、 Shareholding before and after the passive reduction plan
Shareholder name share nature shares held before this passive reduction plan shares held after this passive reduction plan (November 24, 2021) (January 4, 2022)
Proportion of shares (shares) to total share capital proportion of shares (shares) to total share capital
Rexroth China holds 5379188537.98% shares in total 5199818897.71%
Including: shares with unlimited sales conditions 5379188537.98% 5199818897.71%
Shares with limited sales conditions 0000
Rexroth China holds 5539944358.22% shares in total 5360574717.95%
And its consistency, including: shares with unlimited sales conditions 5539944358.22% 5360574717.95%
Actor limited sale condition shares 0000
Note: 1. Shenzhen Laishi Kaiji Investment Consulting Co., Ltd. is the concerted action of Laishi China.
3、 Other relevant instructions
1. The passive reduction plan of Rexroth China complies with relevant laws, regulations and rules such as the securities law, the guidelines for the standardized operation of listed companies of Shenzhen Stock Exchange, several provisions on the reduction of shares by shareholders, directors, supervisors and senior managers of listed companies, and the implementation rules for the reduction of shares by shareholders, directors, supervisors and senior managers of listed companies of Shenzhen Stock Exchange Business rules.
2. Since the date when the company first issued the pre disclosure announcement on the possible passive reduction of the company’s shares by Raffles China and its concerted actors on December 8, 2018, as of January 4, 2022, Raffles China and its concerted actors have passively reduced 1201181695 shares of the company (accounting for 17.82% of the company’s total share capital), There is no reduction in the shares of the company by Rexroth China and its persons acting in concert.
As of January 4, 2022, Raffles China holds 519981889 shares of the company, accounting for 7.71% of the total share capital of the company, accumulatively pledges 491198274 shares of the company, accounting for 7.29% of the total share capital of the company, and accumulatively freezes 519981889 shares of the company, accounting for 7.71% of the total share capital of the company; Rexroth China and its persons acting in concert held 536057471 shares of the company, accounting for 7.95% of the total share capital of the company, pledged 507264690 shares of the company, accounting for 7.53% of the total share capital of the company, and frozen 536057471 shares of the company, accounting for 7.95% of the total share capital of the company.
3. This reduction is a passive reduction of Laishi China. Laishi China and its persons acting in concert have been actively negotiating with creditors and relevant courts to solve debt issues, and also actively seeking strategic investors to jointly resolve the debt crisis.
4. The passive reduction of shares has been pre disclosed in accordance with relevant regulations, and the actual reduction is in line with the previously disclosed reduction plan. As of January 4, 2022, more than half of the passive reduction plan has been reduced, and the passive reduction plan has not been implemented yet.
5. At present, the company has no controlling shareholder and no actual controller. The implementation of the passive reduction plan has no impact on the corporate governance structure and sustainable operation.
6. The company will continue to pay attention to the follow-up progress of the matter, urge shareholders to strictly abide by relevant laws, regulations, departmental rules and normative documents, and perform information disclosure obligations in a timely and legal manner.
4、 Documents for future reference
Notification letter on the company’s passive reduction plan to reduce more than half of its holdings.
It is hereby announced.
Shanghai Raas Blood Products Co.Ltd(002252)
Board of directors
January 6, 2002
